Akums Drugs & Pharmaceuticals Ltd share price advanced by 5.14% to Rs 696.5 after the company's net profit soared by 24.15% to Rs 100.98 crore, while revenue from operations slightly gained 0.76% to Rs 1166.63 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.84 lakh crore, easing 5.15%. It has inched up 0.86% over last one week and rose by 12.01% in last one month while the market capitalization of Akums Drugs & Pharmaceuticals Ltd has improved by 5.67% and 25% in the same period respectively. Profit before tax (PBT) of Akums Drugs & Pharmaceuticals Ltd stood at Rs 139.24 crore in Q2 FY26, expanding by 45.57% year-on-year, and advancing by 14.87% quarter-on-quarter. EBITDA came in at Rs 144 crore, jumping 41.14% YoY and rallying 23.95% sequentially. Total expenses softened by 1.27% to Rs 1033.02 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 682.12 crore, going up by 16.22% YoY, while employee benefits expense was at Rs 201.43 crore, ticking higher by 1.21% YoY. For the TTM ended FY26, revenue from operations inched higher 5.85% to Rs 4359.02 crore, while net profit tanked by 25.42% to Rs 256.4 crore, compared to previous TTM. EBITDA surged by 41246% to Rs 393.29 crore, and PBT registered a growth of 10.67% to Rs 382.1 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1181.2 crore in FY26, as against Rs 465.2 crore in FY25. Akums Drugs & Pharmaceuticals Ltd rallied 41.71% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.63% during the same period.